Morepen Laboratories Ltd

BSE : MOREPENLAB13 Dec 2024

Pharmaceuticals

₹

-1.22 (-1.38%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Morepen Laboratories Ltd

Morepen Laboratories Ltd

Pharmaceuticals

BSE : MOREPENLAB13 Dec 2024

₹

-1.22 (-1.38%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
06-Nov-2024	BC	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve unaudited standalone and consolidated	11-Nov-2024
11-Sep-2024	BC	AGM 28/09/2024 Please find enclosed proceedings of the 39th Annual General Meeting held through VC/ OAVM on Saturday, 28th September 2024 at 1.00 p.m. (IST). (As per BSE Announcement Dated on 2	28-Sep-2024
11-Sep-2024	BC	Annual General Meeting	22-Sep-2024
18-Sep-2024	BC	Please find enclosed intimation for completion of tenure of Independent Directors, namely, Mr. Manoj Joshi, Mr. Sukhcharan Singh and Mr. Bhupender Raj Wadhwa.	18-Sep-2024
27-Aug-2024	BC	Please find enclosed letter comprising outcome of board meeting held on 27-August-2024. Please find enclosed update on disclosure submitted on August 27, 2024. (As per BSE Announcement Dated on	27-Aug-2024

No Rights has been declared by MOREPENLAB

Book Closure

Record Date	Split Date	Purpose
11-Nov-2024	-	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve unaudited standalone and consolidated
28-Sep-2024	-	AGM 28/09/2024 Please find enclosed proceedings of the 39th Annual General Meeting held through VC/ OAVM on Saturday, 28th September 2024 at 1.00 p.m. (IST). (As per BSE Announcement Dated on 2
22-Sep-2024	01 Jan'1900	Annual General Meeting
18-Sep-2024	-	Please find enclosed intimation for completion of tenure of Independent Directors, namely, Mr. Manoj Joshi, Mr. Sukhcharan Singh and Mr. Bhupender Raj Wadhwa.
27-Aug-2024	-	Please find enclosed letter comprising outcome of board meeting held on 27-August-2024. Please find enclosed update on disclosure submitted on August 27, 2024. (As per BSE Announcement Dated on

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Morepen Laboratories Ltd ₹87.12(-1.22/-1.38%)	87.12	-1.22	4,773.77	95.64	33.64	4.16
Ambalal Sarabhai Enterprises Ltd ₹64.13(-1.44/-2.20%)	64.13	-1.44	491.45	63.76	55.77	10.90
Astrazeneca Pharma India Ltd ₹6,603.60(-32.40/-0.49%)	6,603.60	-32.40	16,509.00	39.83	128.25	24.30
Bliss GVS Pharma Ltd ₹175.85(+2.05/1.18%)	175.85	+2.05	1,852.87	32.77	22.93	1.81
Amrutanjan Health Care Ltd ₹749.90(-1.70/-0.23%)	749.90	-1.70	2,168.01	26.46	45.61	7.28
Abbott India Ltd ₹28,658.65(-63.45/-0.22%)	28,658.65	-63.45	60,899.63	25.79	47.40	17.30

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	21.26	15.38	40.47	12.79	9.36
Net Cash from Operating Activities	77.36	-102.12	-68.87	49.31	10.86
Net Cash Used In Investing Activities	-83.60	-36.20	-22.64	-69.09	-12.08
Net Cash Used In Financing Activities	0.28	144.20	66.41	47.46	4.65
Net Inc./Dec In Cash And Cash Equivalents	-5.96	5.88	-25.09	27.68	3.43
Cash And Cash Equivalents At End Of The Year	15.30	21.26	15.38	40.47	12.79

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

35.65%

FII Shareholding

2.08%

DII Shareholding

1.71%

Public Shareholding

60.56%

**Promoter pledged shareholding 35.65%

About Morepen Laboratories Ltd

Morepen Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 4773.77 crores. It has reported a sales of Rs. 383.7 crores and a net profit of Rs. 31.93 crores for the quarter ended December 2018. The company management includes Sushil Suri, Sushil Suri,Vipul Kumar Srivatava,Sanjay Suri,Praveen Kumar Dutt,Savita,Sharad Jain (Morepen Laboratories Ltd) among others.

Chairman

Sushil Suri

Registered office

Morepen Village,Nalagarh Road Near Baddi,Solan,Himachal Pradesh,173205

FAX :91-01795-276204

Background

Incorporation Year1984

Face Value₹2

Market Lot1